Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Cardiovascular Stroke

quinoxalines has been researched along with Cardiovascular Stroke in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Andres, AM; Germano, JF; Gottlieb, RA; Huang, C; Mentzer, RM; Piplani, H; Saadaeijahromi, H; Sin, J; Song, Y; Stotland, A; Taylor, DJR; Tucker, KC1
Genade, S; Genis, A; Huisamen, B; Lochner, A; Ytrehus, K1
Damilano, F; Emanueli, C; Hirsch, E; Katare, R; Madeddu, P; Meloni, M; Siragusa, M1
Abbate, A; Mezzaroma, E; Seropian, IM; Toldo, S; Van Tassell, BW1
Abbate, A; Damilano, F; Harrington, J; Hirsch, E; Mezzaroma, E; Ockaili, R; Seropian, IM; Smithson, L; Toldo, S; Van Tassell, BW1
Hering, T1
Donat, U; Felix, SB; Frenzel, M; Krieg, T; Kroemer, HK; Maas, O; Rütz, T1
Bolli, R; Kodani, E; Shinmura, K; Takano, H; Tang, XL; Xuan, YT1

Other Studies

9 other study(ies) available for quinoxalines and Cardiovascular Stroke

ArticleYear
Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover.
    Scientific reports, 2020, 05-19, Volume: 10, Issue:1

    Topics: Animals; Biomarkers; Cell Line; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Heart Function Tests; Male; Mice; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardial Infarction; Myocytes, Cardiac; Quinoxalines; Rats; Ubiquitin-Protein Ligases; Ventricular Remodeling

2020
Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.
    Journal of pineal research, 2008, Volume: 45, Issue:4

    Topics: Adrenergic Antagonists; Animals; Colforsin; Cyclic AMP; Guanylate Cyclase; Heart; Indoles; Isoproterenol; Male; Maleimides; Melatonin; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; p38 Mitogen-Activated Protein Kinases; Propranolol; Protein Kinase C; Quinoxalines; Rats; Rats, Wistar; Receptors, Melatonin; Tryptamines

2008
Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.
    Circulation research, 2010, Mar-05, Volume: 106, Issue:4

    Topics: Animals; Apoptosis; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Inflammation; Leukocytes; Male; Mice; Morpholines; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Recovery of Function; Regeneration; RNA Interference; Signal Transduction; Thiazolidinediones; Time Factors; Transfection; Ventricular Function, Left

2010
Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction.
    Circulation research, 2010, Jul-23, Volume: 107, Issue:2

    Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Genotype; Mice; Mice, Knockout; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenotype; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Thiazolidinediones; Ventricular Function, Left; Ventricular Remodeling

2010
Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice.
    Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:6

    Topics: Animals; Class Ib Phosphatidylinositol 3-Kinase; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Thiazolidinediones; Ventricular Remodeling

2010
[Smoking cessation--assistance for the general practitioner].
    MMW Fortschritte der Medizin, 2011, Apr-07, Volume: 153, Issue:14

    Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2011
Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG.
    British journal of pharmacology, 2008, Volume: 154, Issue:1

    Topics: Animals; Calcium; Carbazoles; Cell Adhesion Molecules; Cell Death; Cell Line; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Microfilament Proteins; Mitochondria, Heart; Mitochondrial Membranes; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoproteins; Piperazines; Quinoxalines; Rats; Sulfones; Triazines; Vardenafil Dihydrochloride

2008
Varenicline: myocardial infarction: nicotine replacement is a better option.
    Prescrire international, 2008, Volume: 17, Issue:93

    Topics: Benzazepines; Europe; Humans; Myocardial Infarction; Nicotine; Quinoxalines; Smoking Cessation

2008
Role of cyclic guanosine monophosphate in late preconditioning in conscious rabbits.
    Circulation, 2002, Jun-25, Volume: 105, Issue:25

    Topics: Animals; Consciousness; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Ischemic Preconditioning, Myocardial; Kinetics; Male; Myocardial Infarction; Myocardial Stunning; Oxadiazoles; Quinoxalines; Rabbits

2002